Plain-English translation of NCT06373601 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different types of drug-coated balloons—Selution (which releases sirolimus) and SeQuent Please Neo (which releases paclitaxel)—to see which one works better at keeping small heart blood vessels open. Both balloons are used during a procedure called angioplasty, where a catheter is threaded to the blocked vessel and the balloon is inflated to restore blood flow. The study will compare how well each balloon prevents the vessel from narrowing again over time.
Small blood vessels in the heart are tricky to treat because they often narrow again after a procedure, even with special drug-coated balloons. This trial aims to find out which medication coating works best for these smaller vessels, so doctors can choose the most effective treatment for their patients.
You likely qualify if…
You likely don't qualify if…
You will undergo a catheter procedure where doctors thread a thin tube to your blocked heart vessel and use one of the two drug-coated balloons to open it. After the procedure, you'll receive phone call check-ins at 1 month and 6 months. At 12 months, you'll return to the hospital for a repeat imaging procedure (angiogram) to see how well the vessel has stayed open. In total, the study lasts one year.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Italy